Cat. No. Name Size Price Add Cart
KI0774Rilmenidine50 mg$729

Chemical Characteristic

Product NameRilmenidine
SynonymsHyperium, Iterium, Tenaxum, S 3341
CAS No.54187-04-1
Molecular Weight 180.25
FormulaC10H16N2O
Chemical Structure

Biological activities

Rilmenidine is an imidazoline α2-adrenoceptor agonist. Rilmenidine inhibits noradrenaline-induced platelet aggregation with an IC50 of 12.7 µM.[1] Rilmenidine has high affinity for imidazoline I1 receptor with a Ki of 52 nM. In the untreated cells and ns-siRNA transfected cells, administration of rilmenidine at the dose of 100 nM for 15 minutes increases ERK phosphorylation to about 3 fold compared with vehicle control.[2] Rilmenidine at the dose of 1 µM inhibits isoproterenolstimulated cAMP accumulation in rabbit iris-ciliary bodies by 43%. Rilmenidine induces large increases in [Ca2+] in rabbit nonpigmented ciliary epithelial cells.[3] Rilmenidine prevents the firing of locus ceruleus and dorsal raphe neurons.[4] Rilmenidine which is microinjected bilaterally into the C1 area of the rostral ventrolateral medulla (RVL), but not nucleus tractus solitarii (NTS) nor caudal ventrolateral medulla (CVL), causes dose-dependent falls in arterial pressure and heart rate at doses an order of magnitude less than required systemically.[5] Rilmenidine administration improves the signs of disease in a Huntington's disease mouse model. Rilmenidine decreases levels of the mutant huntingtin fragment. Rilmenidine induces autophagy in mice and in primary neuronal culture.[6]

Protocols

In vivo: Rilmenidine is obtained in the form of rilmenidine hemifumarate. Rilmenidine hemifumarate is prepared as a stock solution of 10 mg/mL in 20% ethanol and is diluted on the day of experiment to 1 mg/mL in 0.15 m NaCl, 5% Tween-20 and 5% PEG 400 immediately before injection.[6]

References

[1] Pinthong D, et al. The effects of imidazoline agents on the aggregation of human platelets. J Pharm Pharmacol. 2004, 56(2): 213-220. 閵嗏偓閵嗏偓
[2] Li F, et al. Comparison of agmatine with moxonidine and rilmenidine in morphine dependence in vitro: role of imidazoline I(1) receptors. Eur J Pharmacol. 2009, 612(1-3): 1-8. 閵嗏偓閵嗏偓
[3] Chu TC, et al. Rilmenidine-induced ocular hypotension: role of imidazoline1 and alpha 2 receptors. Curr Eye Res. 1996, 15(9): 943-950. 閵嗏偓閵嗏偓
[4] Dresse A, et al. Action of rilmenidine on locus ceruleus and dorsal raphe cells in vivo and in vitro. Am J Cardiol. 1988, 61(7): 32D-34D. 閵嗏偓閵嗏偓
[5] Gomez RE, et al. Rilmenidine lowers arterial pressure via imidazole receptors in brainstem C1 area. Eur J Pharmacol. 1991, 195(2): 181-191. 閵嗏偓閵嗏偓
[6] Rose C, et al. Rilmenidine attenuates toxicity of polyglutamine expansions in a mouse model of Huntington's disease. Hum Mol Genet. 2010, 19(11): 2144-2153. 閵嗏偓閵嗏偓

Please click here to fill online order form, and we will make sure to supply you product with detail information. This process usually takes between 24 to 48 hours, depending on products stock avaliability. All inquires and subsequent projects are handled in the strictest confidence and will be backed by a confidentiality agreement if required.
KareBayTM provides scientists and clinicians with a wide range of biotechnological products and science lab supplies for chemical research and analyzing life processes. KareBay's extensive capabilities include commercializing reagents and kits, manufacturing biotech products and providing contract research services to organizations worldwide. Our many global labs, offices, and business partners enable KareBay to extend its products and services to its customer base around the world.

Our products are used for research, laboratory and further evaluation purposes. They are not for human use.